Konami Digital Entertainment Co., Ltd.

Teijin Pharma Limited

Naotaka Suzuki

Kazuya Takahashi

Satoshi Sugiura

Hiroaki Makino

Kenichiro Kataoka

Gen Unoki

Minoru Imai

Takashi Inubushi

Yoshihiko Narita

Takahiro Ohashi

Tomomi Kosugi

Mika Takakuwa

Yuko Yamakoshi

Joelle Le

Yasuhiro Oue

James Donald Simpson

John Clifford Harris

Aiko Fujino

Robert Dale Mitchell

A card game system in which a game progresses based on game information recorded in a card in each of a plurality of game apparatuses. The game apparatus set as a master apparatus includes a master reception device that receives the game information transmitted from each of the game apparatuses, a permission device that rejects the reception of game information until a start determination device determines to start a specific time and that permits the reception of game information when the start determination device determines to start the specific time, and a rejection device that rejects the reception when an elapse time determination device determines that the set time as the specific time in advance elapses after permitting the reception. Each game apparatus includes a terminal transmission device that transmits the game information to the master reception device.

Card game system and card used in the card system

The Pyrazolo[1,5-a]pyrimidine derivatives represented by formula I and their pharmaceutically acceptable salts exhibit excellent kinase inhibiting activity. Drugs comprising the compounds as effective ingredients are therefore expected to be useful as therapeutic or prophylactic agents for a protein kinase mediated disorder in which kinase is implicated, such as inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth. 

Pyrazolo[1,5-A] pyrimidine derivatives

Growing community of inventors

Tokyo, Japan

Naotaka Suzuki